As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering its marketing team. More: Moderna picks Merck KGaA, Roivant alum as marketing chief Source: fierce
read moreThe device is meant to allow patients more control over their “off” time, or the instances when medicine wears off and symptoms return or worsen. More: Supernus' 4th try proves the charm with long-awaited FDA approval for Parkinson's infusion pump
read moreSeven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened its label as a treatment for diabetic macular edema, which is the leading cause of diabetes-related blindness. More: Roche gains
read moreManufacturing firm Jabil has purchased Maryland-based CDMO Pharmaceutics International for an undisclosed sum. The deal, which closed Monday, immediately arms Jabil with contracting firepower in aseptic filling and freeze-drying services as well as oral solid dose production across multiple stages
read more
Partnership aims to create recombinant nanobodies to treat immune disorders More: Grifols collaborates with startup FcR Therapeutics to develop autoimmune therapies Source: News
read more
Study shows AP-325 offers lasting pain relief without central side effects More: Algiax announces results from phase 2a trial for neuropathic pain treatment Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals